Walmart Inc Analysts Assess Retail Giants Prospects Amid Evolving Consumer Trends Custard Apple Market Growth Faces Export Hurdles Amidst Rising Demand Microsofts GitHub Faces Reliability Crises as AI Coding Rivals Gain Ground Stellantis Turnaround Strategy Prediction Market Oversight and Oura IPO Filing Highlight Key Market Developments Intuit Faces Mixed Analyst Perspectives Amid Market Dynamics Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday SCM Q1 2026 Earnings EPS Misses Estimates as Portfolio Pressures Emerge PEPG Q1 2026 Earnings NarrowerthanExpected Loss Signals Progress in Neuromuscular Pipeline My Size Inc MYSZ Q4 2025 Earnings EPS Falls Short of Expectations Amid Revenue Disclosures SII Q1 2026 Earnings Earnings Beat Amid Precious Metals Tailwinds Stock Edges Lower NVNI Q4 2025 Earnings Massive EPS Miss Amidst Absence of Revenue Data UROY Q1 2026 Earnings Surprise Profit Amid Modest Market Reaction Six Flags Entertainment FUN Surges Over 4 Momentum Builds Toward Key Resistance Boral ARC Acquisition I Corp BCAR Holds Steady Near Trust Value Awaiting Catalyst AgEagle Aerial Systems UAVS Surges 5 as Shares Test Key Resistance at 107 Burning Rock Biotech BNR Plunges 15 as Selling Pressure Intensifies Bold Eagle Acquisition Corp BEAG Holds Steady at 1058 as SPAC Market Awaits Catalyst UK Exports to US Plunge 25 Following Trumps Liberation Day Tariffs Trade Balance Turns Negative UK Exports to US Plunge 25 Following Trumps Liberation Day Tariffs Trade Deficit Emerges Fair Value Estimate Surge 10 Stocks See Biggest Upgrades After Q1 Earnings Morningstar Reports Gilead Sciences GILD Ranked Among Wall Streets Most Profitable Stock Picks with 31 Net Margin and 24 Upside Potential Irans HighSeas Black Market The Network Behind Illicit Oil Flows Electric Vehicles Capture 197 of EU Market in Early 2026 Signaling Accelerated Adoption Bill Ackmans Pershing Square Discloses Major Microsoft Stake Betting on AI Growth WGRX Q1 2026 Earnings Negative EPS and No Revenue Reported Stock Plunges 22 Sunshine Biopharma SBFM Slides 116 as Support at 044 Comes into Focus